Clinical Trial Update: Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy [NA]

View source ↗

Summary

Clinical trial update describing detection of homologous recombination pathway gene mutations in circulating tumor DNA from BRCA-mutated ovarian cancer patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• PARP inhibitor

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Ovarian Cancer | NA | Status: RECRUITING